Flexible and structured survival model for a simultaneous estimation of non-linear and non-proportional effects and complex interactions between continuous variables: Performance of this multidimensional penalized spline approach in net survival trend analysis.

Penalized spline cancer net survival trends generalized additive model interaction multidimensional smoothing non-linear effect non-proportional effect survival model tensor product varying coefficient model

Journal

Statistical methods in medical research
ISSN: 1477-0334
Titre abrégé: Stat Methods Med Res
Pays: England
ID NLM: 9212457

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 12 6 2018
medline: 28 10 2020
entrez: 12 6 2018
Statut: ppublish

Résumé

Cancer survival trend analyses are essential to describe accurately the way medical practices impact patients' survival according to the year of diagnosis. To this end, survival models should be able to account simultaneously for non-linear and non-proportional effects and for complex interactions between continuous variables. However, in the statistical literature, there is no consensus yet on how to build such models that should be flexible but still provide smooth estimates of survival. In this article, we tackle this challenge by smoothing the complex hypersurface (time since diagnosis, age at diagnosis, year of diagnosis, and mortality hazard) using a multidimensional penalized spline built from the tensor product of the marginal bases of time, age, and year. Considering this penalized survival model as a Poisson model, we assess the performance of this approach in estimating the net survival with a comprehensive simulation study that reflects simple and complex realistic survival trends. The bias was generally small and the root mean squared error was good and often similar to that of the true model that generated the data. This parametric approach offers many advantages and interesting prospects (such as forecasting) that make it an attractive and efficient tool for survival trend analyses.

Identifiants

pubmed: 29888650
doi: 10.1177/0962280218779408
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2368-2384

Auteurs

Laurent Remontet (L)

1 Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France.
2 CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive - équipe Biostatistique-Santé; Université Lyon 1, Villeurbanne, France.

Zoé Uhry (Z)

1 Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France.
2 CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive - équipe Biostatistique-Santé; Université Lyon 1, Villeurbanne, France.
3 Département des Maladies Non-Transmissibles et des Traumatismes, Santé Publique France, Saint-Maurice, France.

Nadine Bossard (N)

1 Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France.
2 CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive - équipe Biostatistique-Santé; Université Lyon 1, Villeurbanne, France.

Jean Iwaz (J)

1 Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France.
2 CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive - équipe Biostatistique-Santé; Université Lyon 1, Villeurbanne, France.

Aurélien Belot (A)

4 Cancer Research UK Cancer Survival Group, Faculty of Epidemiology and Population Health, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Coraline Danieli (C)

5 McGill University Health Center, Department of Epidemiology, Biostatistics and Occupational Health, Montreal, QC, Canada.

Hadrien Charvat (H)

6 Division of Prevention, Center for Public Health Sciences, National Cancer Center, Chuo-ku, Tokyo, Japan.

Laurent Roche (L)

1 Hospices Civils de Lyon, Service de Biostatistique-Bioinformatique, Lyon, France.
2 CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive - équipe Biostatistique-Santé; Université Lyon 1, Villeurbanne, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH